(Q44473307)

3 December 2017

title

Neurosteroid secretion in panic disorder (English)

1 reference

3 December 2017

author

Maria Giuseppina Pisu

3

1 reference

3 December 2017

Mariangela Serra

8

0 references

Giampaolo Perna

object named as

Giampaolo Perna

5

0 references

Laura Bellodi

4

object named as

Laura Bellodi

1 reference

3 December 2017

Francesca Brambilla

1

1 reference

3 December 2017

Giovanni Biggio

2

1 reference

3 December 2017

Vesna Bogdanovich-Djukic

6

1 reference

3 December 2017

Robert H Purdy

7

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 May 2003

1 reference

3 December 2017

1 reference

3 December 2017

volume

118

1 reference

3 December 2017

issue

2

1 reference

3 December 2017

page(s)

107-116

1 reference

Hypothalamic-pituitary-adrenal axis activity in panic disorder. 24-hour secretion of corticotropin and cortisol.

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900077-5

7 January 2021

The Panic-Associated Symptom Scale: measuring the severity of panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900077-5

7 January 2021

Salivary Cortisol in Panic Attacks

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900077-5

7 January 2021

Plasma 5alpha-androstane-3alpha,17betadiol, an endogenous steroid that positively modulates GABA(A) receptor function, and anxiety: a study in menopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900077-5

7 January 2021

Allopregnanolone and dehydroepiandrosterone response to corticotropin-releasing factor in patients suffering from Alzheimer's disease and vascular dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900077-5

7 January 2021

The neurosteroid pregnanolone prevents the anxiogenic-like effect of inescapable shock in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900077-5

7 January 2021

Anxiolytic Effect of Progesterone is Mediated by the Neurosteroid Allopregnanolone at Brain GABAA Receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900077-5

7 January 2021

Agoraphobia with panic attacks. Development, diagnostic stability, and course of illness

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900077-5

7 January 2021

The anxiolytic-like effects of the neurosteroid allopregnanolone: interactions with GABA(A) receptors.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900077-5

7 January 2021

Menstrual fluctuation in the symptoms of panic anxiety.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900077-5

7 January 2021

Endocrine and physiological changes during "spontaneous" panic attacks

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900077-5

7 January 2021

Targeted mutations of the corticotropin-releasing factor system: effects on physiology and behavior.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900077-5

7 January 2021

Anxiety and the menstrual cycle in panic disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900077-5

7 January 2021

Anxiolytic activity of an endogenous adrenal steroid

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900077-5

7 January 2021

Physiological and behavioral responses to corticotropin-releasing factor administration: is CRF a mediator of anxiety or stress responses?

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900077-5

7 January 2021

Effects of acute metabolic stress on plasma progesterone and testosterone in male subjects: relationship to pituitary-adrenocortical axis activation.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900077-5

7 January 2021

Modulation of memory processing by glutamic acid receptor agonists and antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900077-5

7 January 2021

Memory-enhancing effects in male mice of pregnenolone and steroids metabolically derived from it.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900077-5

7 January 2021

Dehydroepiandrosterone and its sulfate enhance memory retention in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900077-5

7 January 2021

Effects of paced and non-paced mating stimulation on plasma progesterone, 3 alpha-diol and corticosterone

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900077-5

7 January 2021

Effect of pregnancy on panic attacks.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900077-5

7 January 2021

CSF neuroactive steroids in affective disorders: pregnenolone, progesterone, and DBI.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900077-5

7 January 2021

Pentagastrin-induced sleep panic attacks: panic in the absence of elevated baseline arousal

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900077-5

7 January 2021

Low pregnenolone sulphate plasma concentrations in patients with generalized social phobia

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900077-5

7 January 2021

Psychiatric implications of altered limbic-hypothalamic-pituitary-adrenocortical activity

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900077-5

7 January 2021

Reduction of predator odor-induced anxiety in mice by the neurosteroid 3 alpha-hydroxy-4-pregnen-20-one (3 alpha HP).

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900077-5

7 January 2021

DELINEATION OF TWO DRUG-RESPONSIVE ANXIETY SYNDROMES

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900077-5

7 January 2021

False suffocation alarms, spontaneous panics, and related conditions. An integrative hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900077-5

7 January 2021

Behavioral, cardiovascular, and neuroendocrine profiles following CCK-4 challenge in healthy volunteers: a comparison of panickers and nonpanickers.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900077-5

7 January 2021

Brief standard self-rating for phobic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900077-5

7 January 2021

Plasma levels of neuroactive steroids are increased in untreated women with anorexia nervosa or bulimia nervosa

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900077-5

7 January 2021

The neurosteroid tetrahydroprogesterone counteracts corticotropin-releasing hormone-induced anxiety and alters the release and gene expression of corticotropin-releasing hormone in the rat hypothalamus

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900077-5

7 January 2021

Menstrual cycle-related sensitivity to 35% CO2 in panic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900077-5

7 January 2021

Anti-anxiety effects of progesterone and some of its reduced metabolites: an evaluation using the burying behavior test

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900077-5

7 January 2021

Estrogen-induced panic attacks

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900077-5

7 January 2021

Synthesis, metabolism, and pharmacological activity of 3 alpha-hydroxy steroids which potentiate GABA-receptor-mediated chloride ion uptake in rat cerebral cortical synaptoneurosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900077-5

7 January 2021

Progesterone metabolite allopregnanolone in women with premenstrual syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900077-5

7 January 2021

Neuroactive steroid-serotonergic interaction: responses to an intravenous L-tryptophan challenge in women with premenstrual syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900077-5

7 January 2021

Effects of antidepressant treatment on neuroactive steroids in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900077-5

7 January 2021

Dysregulation of the hypothalamic-pituitary-adrenocortical system in panic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900077-5

7 January 2021

2-Phenyl-imidazo[1,2-a]pyridine derivatives as ligands for peripheral benzodiazepine receptors: stimulation of neurosteroid synthesis and anticonflict action in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900077-5

7 January 2021

Panic induced by carbon dioxide inhalation and lack of hypothalamic-pituitary-adrenal axis activation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900077-5

7 January 2021

Elevated circulatory level of GABA(A)--antagonistic neurosteroids in patients with combat-related post-traumatic stress disorder.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900077-5

7 January 2021

GABA(A) receptor-modulating neuroactive steroid composition in patients with panic disorder before and during paroxetine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900077-5

7 January 2021

Concentrations of 3 alpha-reduced neuroactive steroids and their precursors in plasma of patients with major depression and after clinical recovery.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900077-5

7 January 2021

Neuroactive steroid changes in response to challenge with the panicogenic agent pentagastrin

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900077-5

7 January 2021

Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900077-5

7 January 2021

Anxiolytic activity of the progesterone metabolite 5α-pregnan-3α-ol-20-one

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900077-5

7 January 2021

Dehydroepiandrosterone (DHEA) treatment of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900077-5

7 January 2021

Elevation of the cortisol-dehydroepiandrosterone ratio in drug-free depressed patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-1781%2803%2900077-5

7 January 2021

10.1016/S0165-1781(03)00077-5

Identifiers

DOI

1 reference

3 December 2017

1 reference